4th Annual

Bladder Cancer Symposium 

Saturday, November 5, 2022

VIRTUAL EVENT

Learning Objectives:

At the conclusion of this activity, participants should be able to:

 

  1. Identify alternate treatments that are available for patients with nonmuscle invasive bladder cancer who cannot receive BCG
  2. Explain the role of surgery for patients with nonmuscle invasive bladder cancer
  3. Explain the role of radiation therapy for patients with bladder cancer
  4. Explain the role of systemic neoadjuvant therapy for patients with bladder cancer

 

Continuing Medical Education

Accreditation

The University of Rochester School of Medicine and Dentistry is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Certification

The University of Rochester School of Medicine and Dentistry designates this live activity for a maximum of 2.75 AMA PRA Category 1 Credits TM.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.